Moreover, our findings indicate that high AMBRA1 expression correlates with poor overall survival in STAD patients and is positively associated with T cell CD4+ infiltration (Supplementary Figure S1). The gene discussed is AMBRA1; the disease is gastric adenocarcinoma.